Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2009 2
2011 1
2012 1
2014 2
2015 1
2017 1
2018 1
2019 3
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Norepinephrine-Transporter-Targeted and DNA-Co-Targeted Theranostic Guanidines.
Kortylewicz ZP, Coulter DW, Han G, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. J Med Chem. 2020 Mar 12;63(5):2051-2073. doi: 10.1021/acs.jmedchem.9b00437. Epub 2019 Jul 3. J Med Chem. 2020. PMID: 31268317
Radiosynthesis of microtubule-targeted theranostic methyl N-[5-(3'-radiohalobenzoyl)-1H-benzimidazol-2-yl]carbamates.
Kortylewicz ZP, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. J Labelled Comp Radiopharm. 2018 Apr 29:10.1002/jlcr.3631. doi: 10.1002/jlcr.3631. Online ahead of print. J Labelled Comp Radiopharm. 2018. PMID: 29707803 Free PMC article.
Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma.
Coulter DW, Boettner AD, Kortylewicz ZP, Enke SP, Luther JA, Verma V, Baranowska-Kortylewicz J. Coulter DW, et al. Among authors: kortylewicz zp. J Pediatr Hematol Oncol. 2017 May;39(4):272-281. doi: 10.1097/MPH.0000000000000828. J Pediatr Hematol Oncol. 2017. PMID: 28375942
Biological Evaluation of a Potential Anticancer Agent Methyl N-[5-(3'-Iodobenzoyl)-1H-Benzimidazol-2-yl]Carbamate.
Kortylewicz ZP, Coulter DW, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. Cancer Biother Radiopharm. 2020 Feb;35(1):16-25. doi: 10.1089/cbr.2019.2988. Epub 2019 Nov 5. Cancer Biother Radiopharm. 2020. PMID: 31687840
Preclinical evaluation of investigational radiopharmaceutical RISAD-P intended for use as a diagnostic and molecular radiotherapy agent for prostate cancer.
Kortylewicz ZP, Mack E, Enke CA, Estes KA, Mosley RL, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. Prostate. 2015 Jan;75(1):8-22. doi: 10.1002/pros.22885. Epub 2014 Oct 4. Prostate. 2015. PMID: 25283970
Radiolabeled (R)-(-)-5-iodo-3'-O-[2-(ε-guanidinohexanoyl)-2-phenylacetyl]-2'-deoxyuridine: A new theranostic for neuroblastoma.
Kortylewicz ZP, Coulter DW, Han G, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. J Labelled Comp Radiopharm. 2020 Mar 9:10.1002/jlcr.3836. doi: 10.1002/jlcr.3836. Online ahead of print. J Labelled Comp Radiopharm. 2020. PMID: 32150284
Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer.
Abe M, Kortylewicz ZP, Enke CA, Mack E, Baranowska-Kortylewicz J. Abe M, et al. Among authors: kortylewicz zp. Cancers (Basel). 2011 May 25;3(2):2501-15. doi: 10.3390/cancers3022501. Cancers (Basel). 2011. PMID: 24212821 Free PMC article.
Radioiodinated agents for imaging multidrug resistant tumors.
Kortylewicz ZP, Augustine AM, Nearman J, McGarry J, Baranowska-Kortylewicz J. Kortylewicz ZP, et al. Med Chem. 2009 Mar;5(2):171-81. doi: 10.2174/157340609787582954. Med Chem. 2009. PMID: 19275716
14 results
Jump to page
Feedback